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Human immunodeficiency virus (HIV) continues to be a major global health issue. As per World Health Organization, approximately 36.7 million people were 
living with HIV at the end of 2016 out of which 2.1 million were 
children below 15 years of age [1]. National acquired immuno 
deficiency syndrome (AIDS) Control Organization estimated 
21.17 lakh people living with HIV in India in 2015, out of which 
6.54% were children less than 15 years of age [2]. Malnutrition 
and growth failure are consequences of HIV infection in children 
and are characterized by poor linear and ponderal growth [3-7]. 
HIV infected children have high rates of malnutrition as compared 
to HIV uninfected children despite similar calorie intake [8]. 
Reduced appetite, side effects of medicines, depression, 
malabsorption and increased nutrient requirement during fever 
and infections are possible contributory factors [9]. The use of 
highly active antiretroviral therapy (HAART) has substantially 
improved survival in HIV-infected children [10]. Children on 
HAART show improved growth in height and weight [11-13]. 
They show significant CD4 cell percentage recovery, and 
suppression of viral loads [14-17]. Although the impact of HAART 
on growth is well established, the effect of prior nutritional status 
of HIV patients on the response to HAART in terms of increase 
in CD4 counts and improvement in nutritional status itself is less 
clear [18,19]. The objective of this study was to determine the 
role of nutritional status at the commencement of therapy on the 
clinical and immunologic response to HAART in HIV-infected 
children in India in terms of growth parameters and CD4 counts 
respectively.
MATERIALS AND METHODS
The study was conducted on children upto 12 years of age 
from Pediatric ART Centre at a tertiary care teaching Hospital, 
New Delhi, India. Children were eligible for HAART based on 
clinical and immunologic parameters after a diagnosis of HIV 
infection was made by HIV antibody testing if they were older than 
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18 months or by HIV deoxyribo-nucleic acid polymerase chain 
reaction (DNA PCR) testing if they were younger than 18 months. 
Presumptive diagnosis of severe HIV disease was made in those 
who could not afford DNA PCR if: The infant was confirmed 
HIV antibody positive and diagnosis of any AIDS-indicator 
condition(s) could be made or the infant was symptomatic with two 
or more of the following: (a) Oral thrush, (b) severe pneumonia, 
(c) severe sepsis [20]. HAART was started if patient had WHO 
clinical stage 3 or 4 disease and or CD4 cell percentage <25% in 
<12 months, less than 20 % in 12–35 months, less than 15% in 
36–59 months and <350 cells/cu.mm in >5 years [20]. First-line 
Anti-RetroViral regimens used were: Regimen of 2 nucleoside 
reverse transcriptase inhibitors (NRTI) plus 1 NNRTI 
i.e. Zidovudine (AZT) + Lamivudine (3TC) + Nevirapine (NVP) 
or Efavirenz (EFV) or Stavudine (D4T) + 3TC + NVP or EFV 
[20]. Adherence to treatment was assessed by caregiver reports 
and pill counts. Patients were evaluated at the clinic every month.
The study was conducted as a retrospective record review 
of all HIV infected children who were naive to antiretroviral 
therapy, and who started treatment between January 1st, 2006 and 
December 31st, 2007. Age, weight, height and CD4 cell counts 
were recorded at the initiation of HAART and after 24 months 
of therapy. Undernutrition was defined as “underweight” (weight 
for age < −2 standard deviations (SD), “stunting” (height for age 
< −2 SD) and “wasting” (weight for height < −2 SD). Underweight 
served as indicator for overall nutrition. Weight-for age z-scores 
(WAZ), height for age z-scores and weight for height z scores 
were calculated using WHO growth references 2010 [21].
Once patients had fulfilled the inclusion criteria, they were 
divided into 3 groups based on WAZ. Normal weight was defined 
as a WAZ between −2 and + 2 SD, moderate underweight as a 
WAZ between −2 and −3 SD and severe underweight as a WAZ of 
< −3 SD [21]. Growth and CD4 cell counts were compared among 
these 3 patient groups both pre and post ART. Software used was 
Microsoft office excel 2007 and Statist version 1.4.1. Differences 
between the groups at baseline were determined by one-way 
analysis of variance (ANOVA) testing for parametric variables, 
and chi-square tests for categorical variables. Changes in mean 
values from baseline to month 24 were evaluated for each of the 
patient groups with paired t-tests. Unpaired t-tests and one-way 
ANOVA were used to compare changes in mean values between 
the different groups. A 2-tailed p<0.05 was considered statistically 
significant. Confidence intervals (CI) were noted at the 95% level.
RESULTS
Eighty eight children were put on HAART between January 1st, 
2006 and December 31st, 2007. At 24 months, data was available 
for 79 children only as 3 children had died, 2 were lost to 
follow-up and 4 were transferred to other ART centres during the 
study period. So a total of 79 children were included in the study.
Patients were divided into three groups (normal weight, 
moderate underweight and severe underweight) based on their 
baseline WAZ. Number of patients were significantly more in 
“Severe underweight group” (n=35, 44.30%). Overall 71% (56) 
were underweight, 58.2% (46) were stunted and 38.0% (30) were 
wasted. Baseline patient characteristics are shown in Table 1. 
Sex distribution was homogeneous, Age and CD4 counts were 
comparable in all three groups. CD4 count was not affected 
significantly in underweight patients, and there was no significant 
correlation between weight and CD4 counts (Pearson correlation 
coefficient is −0.04). All three expired children belonged to 
severe underweight group but cause of expiry could not be found.
Weight for age after 24 months of HAART are shown in 
Fig. 1. Weight for age increased significantly in all three groups, 
from 19.03±4.18 to 21.85±3.67(mean difference: 2.82, p<0.001) 
in normal weight group, 16.69±4.53 to 20.57±4.90 (mean 
difference: 3.88, p<0.001) in moderate underweight group and 
13.03±3.95 to 18.57±4.12 (mean difference: 5.54, p<0.001) in 
severe underweight group.
Height for age improved in all three groups but improvement 
was not significant. Weight for height improved significantly in 
both the underweight groups (p<0.05). At 24 months, there was 
no significant difference in the weight for age among the three 
groups. Fig. 2 shows CD4 counts after 24 months of HAART 
in three patient groups. Mean CD4 cell counts increased 
significantly in all three groups: From a mean of 243.30±178.50 
to 913.61±401.46 (p <0.001; CI: 72.95–164.07) in normal 
weight group, from 282.95±173.69 to 931.24±363.54 (p<0.001; 
CI: 74.29–155.49) in moderate underweight group and from 
215.11±85.71 to 775.31±424.43 (p<0.001; CI: 28.4–140.61) 
in severe underweight group. Table 2 shows that there were no 
significant differences in CD4 count among the groups both: Pre-
ART and 24 month post ART.
DISCUSSION
The prevalence of underweight, stunting and wasting in ART-
naïve patients were 71%, 58.2%, 38% respectively. The rates 
Table 1: Baseline characteristics (age, weight and CD4 counts) of the study population
Characteristics All patients (%) Normal weight (%) Moderate underweight (%) Severe underweight (%) p value
No of children 79 23 (29.11) 21 (26.58) 35 (44.30) p<0.05
Age (years) 7.14±2.96 6.65±2.33 6.86±3.05 7.63±3.26 NS
Sex
Male 59 (74.68) 17 (73.91) 15 (71.43) 27 (77.14) NS
Female 20 (25.32) 6 (26.09) 6 (28.57) 8 (22.86)
CD 4 counts per mm3 241.35±143.87 243.30±178.50 282.95±173.69 215.11±85.71 NS
Age and CD4 counts are expressed as mean±SD, ANOVA was used to compare the three groups. SD: Standard deviation, NS: Not significant, ANOVA: Analysis of variance
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of underweight and stunting were almost similar to a study 
conducted in South India by Padmapriyadarsini et al, which were 
63% and 58% respectively but higher than that found in south 
Africa study conducted by Naidoo et al. [6,19]. This shows that 
malnutrition in HIV infected children is more prevalent in India 
as compared to Africa.
The present study showed that 24 months after starting 
treatment with HAART, there was statistically significant 
increase in weight of children in all three groups which means 
that underlying malnutrition did not affect response to HAART 
in terms of growth. This observation was similar to that found 
in a study from Africa conducted by Naidoo et al., 2010 [19]. 
Whereas study conducted in South India by Bandopadhyay et al., 
2008 showed that the nutritional response to HAART was poorer 
in malnourished children as compared to nutritionally normal 
counterparts [18].
Present study also showed that CD4 counts increased 
significantly in all three groups meaning thereby that underlying 
malnutrition did not affect the immunologic response to HAART 
too. Similar results were found in studies from Africa by Naidoo 
et al and Singapore by Paton et al [17,19].
Small sample size was the major limitation of our study. 
Moreover being a retrospective study, we couldn’t collect the data 
of patients who expired or lost to follow-up. More studies are 
needed as only few studies have been conducted in this area and 
results of different studies vary.
CONCLUSION
Our study showed that underlying malnutrition did not 
affect nutritional and immunological response to HAART. 
Clinical implication of this study lies in provision of nutritional 
supplements to HIV patient’s along with HAART as supplements 
will be useful if further studies show poor response to HAART in 
malnourished children.
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